Health Condition 1: null- Alopecia Areata Health Condition 2: L639- Alopecia areata, unspecified
Conditions
Interventions
Intervention1: Group 2 - Intralesional injection of triamcinolone acetonide: Triamcinolone acetonide injection (10mg/ml)will be injected intradermally with disposable insulin (1 cc) syringe as multipl
Sponsors
Department of Dermatology
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with clinical diagnosis of alopecia areata restricted to scalp. 2.Patients with disease of limited area not requiring systemic treatment. 3.Patients above the age of 18 years.
Exclusion criteria
Exclusion criteria: 1.Patients suffering from any significant systemic illness. 2.History of taking intralesional injections or any topical or systemic treatment for alopecia areata in past twelve weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage regrowth and uniformity of regrowth and to compare the efficacy of intralesional triamcinolone acetonide to triamcinolone acetonide through microneedlingTimepoint: 0 weeks 3 weeks 6 weeks 9 weeks 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Atrophy over the patchTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks;Pigmentation changesTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks;TelangectasiaTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks | — |
Countries
India
Contacts
Public ContactAstha Arora
Government Medical College and Hospital,Sector 32, Chandigarh
Outcome results
None listed